The historical data provided represents the financial performance of Apollo Hospital in terms of revenue, cost of revenue, gross profit, operating income, net income, cash from operating activities, capital expenditure, and free cash flow.
From the data, we can observe that Apollo Hospital has experienced consistent revenue growth over the years, with an average growth rate of 16.25%. However, there was a decline in revenue growth in 2020 due to the impact of the COVID-19 pandemic. The revenue is projected to continue growing in 2022 and 2023.
The cost of revenue has also increased over the years, but at a slower pace compared to revenue growth. This has resulted in a steady gross profit margin, indicating efficient cost management.
Operating income has shown fluctuations, with a significant increase in 2022. This suggests that Apollo Hospital has been able to improve its operational efficiency and profitability. The operating margin has also shown improvement over the years.
Net income has varied, with a significant increase in 2022. This indicates that Apollo Hospital has been able to generate higher profits after accounting for all expenses and taxes. The net margin has also shown improvement over the years.
Cash from operating activities has been positive and has increased steadily, indicating that Apollo Hospital has been able to generate sufficient cash flow from its core operations. This demonstrates the company’s ability to fund its operations and investments.
Capital expenditure has been negative in most years, indicating that Apollo Hospital has been investing more in its infrastructure and expansion than it has been generating from its operations. However, the free cash flow has been positive in most years, indicating that the company has been able to generate excess cash after meeting its capital expenditure requirements.
Overall, the data suggests that Apollo Hospital has been able to achieve consistent revenue growth, improve profitability, and generate positive cash flow. This indicates a strong financial performance and market value for the company.